Intellective Bio Milestones
Time:November 22, 2023
Author:Intellective Biologics
2018
2018.04.27: Intellective Bio registered and established in Xiangcheng, Suzhou.
2018.05: 100 sqm temporary R&D lab became operational.
2018.07: Official signing of the investment agreement; laboratory renovation began.
2018.09: 2000 sqm R&D laboratory (including 200 L pilot scale) became operational; GMP renovation initiated.
2018.12: 5700 L workshop renovation completed; validation commenced.
2019
2019.03: 5700 L GMP workshop officially operational.
2019.05: Xiangcheng Plant I obtained the Drug Production Licence.
2020
2020.01: Intellective Bio awarded "High-Quality Development Innovation Award."
2020.05: Awarded "Gusu Innovation and Entrepreneurship Leading Talent."
2020.11: Completed Series A financing of several hundred million RMB.
2020.12: Xiangcheng Plant I passed EU QP Certification; Passed ISO Quality System Certification.
2021
2021.01: Selected as a Jiangsu Provincial Potential Unicorn Enterprise.
2021.04: Changshu Plant III base obtained construction permit.
2021.06: Completed Series B financing of several hundred million RMB.
2021.08: Changshu Plant III production building topped out.
2021.12: Xiangcheng Plant I passed EU QP inspection; Changshu Plant III fully topped out.
2022
2022.03: Changshu Plant III main structure accepted.
2022.04: Intellective Bio founder Alex Li was newly elected as a representative to the 17th Suzhou Municipal People's Congress.
2022.05: SIP Plant II obtained the Drug Production Licence; Changshu Plant III 6000 L stainless steel reactor arrived on site.
2022.06: Completed Series C financing of several hundred million RMB.
2022.10: Changshu Plant III 6000 L stainless steel reactor trial production initiated.
2022.12: SIP Plant II passed EU QP inspection.
2023
2023.01: Xiangcheng Plant I passed inspection for added production scope on the licence.
2023.04: SIP Plant II completed on-site PAI and GMP Compliance dynamic inspection.
2023.07: Recognised as a National-level "Little Giant" specialised and innovative SME; Changshu Plant III passed EU QP inspection.
2023.08: Changshu Plant III passed on-site inspection for production license addition/change of address.
2023.10: Number of clinical trial approvals supported for clients surpassed 50.
- 2023.11: Intellective Bio's CEO invited to attend the 30th APEC CEO Summit.








